
Sign up to save your podcasts
Or


China will use policy tools, including RRR cuts in a timely way, to support the real economy, especially industries and small firms hit by the COVID-19 pandemic, and will lower financing costs, according to the State Council's Executive Meeting chaired by Premier Li Keqiang.
https://m.21jingji.com/article/20220414/herald/df90f58d41b70cc9a2a32bf947155bdd.html
China granted provinces their full allocation of special bonds to be used for infrastructure investment, an effort to step up stimulus to boost an economy overshadowed by a worsening Covid-19 outbreak. The issuance of local-government special bonds has progressed much faster and is more advanced this year than in previous years.
https://m.21jingji.com/article/20220413/herald/cff04fc5366921ca3e8faade1bafbc32.html
As part of the measures advocated to steady businesses’ expectations, China pledged to support financing of privately run firms through listings, mergers and acquisitions, and improve the supportive mechanism for private firms to issue bonds. The proposition vows to support listed real estate companies to actively transform to a new development model according to the law and regulations, strengthen their own risk management, and promote the virtuous cycle and healthy development of the industry.
https://m.21jingji.com/article/20220412/herald/c5ae13ce6acb7ab9ee35342982db5271.html
China unveiled guidelines for accelerating the building of a unified national market, envisioning breaking local protection and market fragmentation and unblocking key sticking points that weigh on economic circulation, as part of a wide-ranging push for an effectively regulated, fairly competitive and fully open market across the country. The new guidelines issued by the Communist Party of China (CPC) Central Committee and the State Council, set out to further unify the basic systems and rules, including those for property rights protection, market access, fair competition and social credit.
https://m.21jingji.com/article/20220411/herald/845266fa2d2fca1cb187b89c61e7b28f.html
China has approved the production of the first domestically made vaccine against HPV at the end of 2019, before which the high prices and limited supply of imported vaccines remained a burden for many in the country. China has become the third country globally to achieve an independent cervical cancer vaccine supply. In terms of safety and efficiency, the effects of domestic vaccines are comparable to imported ones, but they cost much less.
https://m.21jingji.com/article/20220408/herald/885478b7987fa746a1b29048a3974c99.html
From the publisher's feed